Table 3.
Univariate Kaplan-Meier analysis of C-reactive protein (CRP) as a prognostic factor for overall survival and recurrence-free survival.
| Localized | Metastatic | |||||
|---|---|---|---|---|---|---|
| Pathological CRP | Normal CRP | Log Rank Test | Raised CRP | Pathological CRP | Log Rank Test | |
| 5 years overall survival (95% CI) | 65.6% (47.9–79.8) |
92.7% (79.6–97.6) |
0.004 | 12.5% (4.1–32.4) |
50.0% (24.4–75.6) |
0.010 |
| 5 years recurrence-free survival (95% CI) | 54.8% (37.4–71.1) |
79.5% (65.1–89.0) |
0.024 | 13.0% (4.3–33.5) |
45.5% (20.3–73.2) |
0.076 |